Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
Neurodegeneration
Autophagy
Parkinson's disease
Pathological Immune Response
ALS
Biopharma
Toxic Protein Clearance
Drug Discovery
Health Care
Therapeutics
Huntington's disease
Drug Development
Road to the Cure
Alzheimer's disease
Disease-modifying treatment
alpha-synuclein
Date founded
2008
Funding rounds raised
Total raised
$500K
from 1 investors over 1 rounds
N
Neuropore Therapies, Inc. raised $500K on February 17, 2020
Investors: The ALS Association